Question

In: Finance

Firm C is considering a project with an up-front cost at t = 0 of $1500....

Firm C is considering a project with an up-front cost at t = 0 of $1500. (All dollars in this problem are in thousands.) The project’s subsequent cash flows are critically dependent on whether a competitor’s product is approved by the Food and Drug Administration (FDA). If the FDA rejects the competitive product, C’s product will have high sales and cash flows, but if the competitive product is approved, that will negatively impact company C. There is a 75% chance that the competitive product will be rejected, in which case the expected cash flows will be $500 at the end of each of the next seven years (t = 1 to 7). There is a 25% chance that the competitor’s product will be approved, in which case the expected cash flows will be only $25 at the end of each of the next seven years (t = 1 to 7). Company C will know for sure one year from today whether the competitor’s product has been approved. Company C is considering whether to make the investment today or to wait a year to find out about the FDA’s decision. If it waits a year, the project’s up-front cost at t = 1 will remain at $1,500, the subsequent cash flows will remain at $500 per year if the competitor’s product is rejected and $25 per year if the alternative product is approved. However, if company C decides to wait, the subsequent cash flows will be received only for six years (t = 2 ... 7). Assuming that all cash flows are discounted at 10%, if Firm C chooses to wait a year before proceeding, how much will this increase or decrease the project’s expected NPV in today’s dollars (i.e., at t = 0), relative to the NPV if it proceeds today

Solutions

Expert Solution

Present Value(PV) of Cash Flow:
(Cash Flow)/((1+i)^N)
i=discount rate =10%=0.10
N=Year   of Cash Flow
NPV if FIRM C PROCEEDS TODAY
Expected annual cash flow=75%*500+25%*25 $381.25
$0
N Year 0 1 2 3 4 5 6 7
a Initial cash flow -$1,500
b Expected annual cash flow $381 $381 $381 $381 $381 $381 $381
CF=a+b Net Cash Flow -$1,500 $381 $381 $381 $381 $381 $381 $381 SUM
PV=CF/(1.10^N) Present Value of Cash Flow -$1,500 $346.591 $315.083 $286.439 $260.399 $236.726 $215.206 $195.642 $356.085
NPV=Sum of PV Expected Net Present Value $356.085
NPV IF FIRM C CHOOSES TO WAIT A YEAR BEFORE PROCEEDING
N Year 0 1 2 3 4 5 6 7
a Initial cash flow -1500
b Annual After tax Maintenance=15000*0.35 $500 $500 $500 $500 $500 $500
CF=a+b Net Cash Flow -$1,500 $500 $500 $500 $500 $500 $500 SUM
PV=CF/(1.1^N) Present Value of Cash Flow $0 -$1,363.636 $413.223 $375.657 $341.507 $310.461 $282.237 $256.579 $616.028
NPV=Sum of PV Net Present Value $616.028
INCREASE IN EXPECTED NPV IN TODAY'S DOLLAR($000) $259.943 (616.028-356.085)
INCREASE IN EXPECTED NPV IN TODAY'S DOLLAR $259,943

Related Solutions

A project with an up-front cost at t = 0 of $1500 is being considered by...
A project with an up-front cost at t = 0 of $1500 is being considered by Nationwide Pharmaceutical Corporation (NPC). (All dollars in this problem are in thousands.) The project's subsequent cash flows are critically dependent on whether a competitor's product is approved by the Food and Drug Administration. If the FDA rejects the competitive product, NPC's product will have high sales and cash flows, but if the competitive product is approved, that will negatively impact NPC. There is a...
A project with an up-front cost at t = 0 of $1500 is being considered by...
A project with an up-front cost at t = 0 of $1500 is being considered by Nationwide Pharmaceutical Corporation (NPC). (All dollars in this problem are in thousands.) The project's subsequent cash flows are critically dependent on whether a competitor's product is approved by the Food and Drug Administration. If the FDA rejects the competitive product, NPC's product will have high sales and cash flows, but if the competitive product is approved, that will negatively impact NPC. There is a...
1. A project with an up-front cost at t=0 of $1500 is being considered by Nationwide...
1. A project with an up-front cost at t=0 of $1500 is being considered by Nationwide Pharmaceutical Corporation (NPC). (All dollars in this problem are in thousands.) The project’s subsequent cash flows are critically dependent on whether a competitor’s product is approved by the Food and Drug Administration. If the FDA rejects the competitive product, NPC’s product will have high sales and cash flows, but if the competitive product is approved, that will negatively impact NPC. There is a 75%...
A project with an up-front cost at t=0 of $1500 is being considered by Nationwide Pharmaceutical...
A project with an up-front cost at t=0 of $1500 is being considered by Nationwide Pharmaceutical Corporation (NPC). (All dollars in this problem are in thousands.) The project’s subsequent cash flows are critically dependent on whether a competitor’s product that is now under development is approved by the Food and Drug Administration. If the FDA rejects the competitive product upon the completion of its development, NPC’s product will have high sales and cash flows, but if the competitive product is...
3. A project with an up-front cost at t=0 of $1500 is being considered by Nationwide...
3. A project with an up-front cost at t=0 of $1500 is being considered by Nationwide PharmaceuticalCorporation (NPC). (All dollars in this problem are in thousands.) The project’s subsequent cash flows arecritically dependent on whether a competitor’s product that is now under development is approved by the Food and Drug Administration. If the FDA rejects the competitive product upon the completion of its development, NPC’s product will have high sales and cash flows, but if the competitive product is approved,...
2. A project with an up-front cost at t=0 of $1500 is being considered by Nationwide...
2. A project with an up-front cost at t=0 of $1500 is being considered by Nationwide Pharmaceutical Corporation (NPC). (All dollars in this problem are in thousands.) The project’s subsequent cash flows are critically dependent on whether a competitor’s product that is now under development is approved by the Food and Drug Administration. If the FDA rejects the competitive product upon the completion of its development, NPC’s product will have high sales and cash flows, but if the competitive product...
1. A project with an up-front cost at t=0 of $1500 is being considered by Nationwide...
1. A project with an up-front cost at t=0 of $1500 is being considered by Nationwide Pharmaceutical Corporation (NPC). (All dollars in this problem are in thousands.) The project’s subsequent cash flows are critically dependent on whether a competitor’s product is approved by the Food and Drug Administration. If the FDA rejects the competitive product, NPC’s product will have high sales and cash flows, but if the competitive product is approved, that will negatively impact NPC. There is a 75%...
A project has an initial, up-front cost of $10,000, at t = 0. The project is...
A project has an initial, up-front cost of $10,000, at t = 0. The project is expected to produce cash flows of $2,200 for the next three years. The project’s cash flows depend critically upon customer acceptance of the product. There is a 60% probability that the product will be wildly successful and produce CFs of $5,000, and a 40% chance it will produce annual CFs of -$2,000. At a 10% WACC, what is this project’s NPV with abandonment option?...
A company is considering a project that has an up-front cost paid today at t =...
A company is considering a project that has an up-front cost paid today at t = 0. The project will generate positive cash flows of $50,175 a year at the end of each for the next 5 years. The project’s NPV is $87,983 and the company’s return on the project is 8.3 percent. What is the project’s payback?
A company is considering a project that has an up-front cost paid today at t =...
A company is considering a project that has an up-front cost paid today at t = 0. The project will generate positive cash flows of $59,529 a year at the end of each for the next 6 years. The project’s NPV is $89,007 and the company’s return on the project is 9.3 percent. What is the project’s payback?
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT